Literature DB >> 6498086

Cellular uptake of clindamycin and lincomycin.

C S Easmon, J P Crane.   

Abstract

Neither clindamycin nor lincomycin killed intracellular Staphylococcus aureus over a 4-h period. Bio-assay of neutrophil sonicates after exposure to antibiotic showed the presence of active clindamycin at approximately 20 times the extracellular concentration. Clindamycin and lincomycin kill staphylococci relatively slowly, particularly in cell culture medium and balanced salt solution. This might account for their failure to kill intracellular staphylococci despite intracellular accumulation. The neutrophil experiments could not be extended to a time period (20 h) over which the antibiotics would kill S. aureus, as the presence of these bacteria within neutrophils for this length of time resulted in considerable cell lysis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6498086      PMCID: PMC2040999     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  3 in total

1.  Antibiotic uptake by alveolar macrophages.

Authors:  J D Johnson; W L Hand; J B Francis; N King-Thompson; R W Corwin
Journal:  J Lab Clin Med       Date:  1980-03

2.  Clindamycin uptake by human neutrophils.

Authors:  M S Klempner; B Styrt
Journal:  J Infect Dis       Date:  1981-11       Impact factor: 5.226

3.  Antibiotic entry into human polymorphonuclear leukocytes.

Authors:  R C Prokesch; W L Hand
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

  3 in total
  12 in total

Review 1.  Activity of antibiotics against microorganisms ingested by mononuclear phagocytes.

Authors:  P J van den Broek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

Review 2.  Optimum treatment of intracellular infection.

Authors:  M Maurin; D Raoult
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

3.  Penetration of brodimoprim into human neutrophils and intracellular activity.

Authors:  P C Braga; M Dal Sasso; S Maci; G Bondiolotti; E Fonti; S Reggio
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

4.  Antimicrobial susceptibility of ileal symbiont intracellularis isolated from pigs with proliferative enteropathy.

Authors:  S McOrist; R A Mackie; G H Lawson
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

5.  Intracellular activity of tosufloxacin (T-3262) against Salmonella enteritidis and ability to penetrate into tissue culture cells of human origin.

Authors:  T Noumi; N Nishida; S Minami; Y Watanabe; T Yasuda
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

6.  Antimicrobial activity against intraosteoblastic Staphylococcus aureus.

Authors:  Florent Valour; Sophie Trouillet-Assant; Natacha Riffard; Jason Tasse; Sacha Flammier; Jean-Philippe Rasigade; Christian Chidiac; François Vandenesch; Tristan Ferry; Frédéric Laurent
Journal:  Antimicrob Agents Chemother       Date:  2015-01-20       Impact factor: 5.191

7.  Reduction of wall degradability of clindamycin-treated staphylococci within macrophages.

Authors:  J Wecke; L Johannsen; P Giesbrecht
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

Review 8.  Activity of antibiotics against Staphylococcus aureus within polymorphonuclear neutrophils.

Authors:  R J Yancey; M S Sanchez; C W Ford
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

9.  Uptake of ciprofloxacin by macrophages.

Authors:  C S Easmon; J P Crane
Journal:  J Clin Pathol       Date:  1985-04       Impact factor: 3.411

10.  Evaluation of antibacterial agents in a high-volume bovine polymorphonuclear neutrophil Staphylococcus aureus intracellular killing assay.

Authors:  M S Sanchez; C W Ford; R J Yancey
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.